NEW DELHI: Seven Indian pharma companies are working to develop a vaccine against
1. Bharat Biotech,
2. Serum Institute,
3. Zydus Cadila,
4. Panacea Biotec,
5. Indian Immunologicals,
6. Mynvax
7. Biological E
are among the domestic pharma firms working on the coronavirus vaccines in India.

Now the rising number of novel coronavirus cases increasing at a pace of daily highs in the country for the past few days, India's first indigenous Covid-19 vaccine Covaxin got a nod from the AIIMS Ethics Committee on Saturday to start human trials from Monday.
AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting phase I and II human trials of Covaxin. In phase I, the vaccine would be tested on 375 volunteers and a maximum of 100 of them would be from AIIMS.

Anybody willing to participate in India's first Covid-19 vaccine trial can send an SMS to or call on 7428847499